Program
Symposium
1. Silent Atrial Fibrillation: Epidemiology, Diagnosis, and Treatment
July 25 (Thu) 08:30-10:00 Room 1 (Main Hall, 1F, Conference Center)
Chairs Shinichi Niwano, Department of Cardiovasucular Medicine, Kitasato University School of Medicine, Japan
Jonathan M. Kalman, Department of Medicine, University of Melbourne, Australia/Heart Rhythm Services, Royal Melbourne Hospital, Australia
SY1-1-KL.
Jonathan M. Kalman, Department of Medicine, University of Melbourne, Australia/Heart Rhythm Services, Royal Melbourne Hospital, Australia
SY1-2. Comparison of 24-Hour vs. 2-Week Continuous Monitoring for Detecting Unknown Atrial Fibrillation Among Patients Without Prior Episodes of Atrial Fibrillation in Japan (REAL-AF study)
Koichi Nagashima, Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Japan
SY1-3. Monitoring and Detecting Silent Atrial Fibrillation Using Wearable Devices in an Era of Digital Evolution
Keitaro Senoo, Department of Cardiac Arrhythmia Research and Innovation, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Japan
SY1-4. Left Ventricular Stiffness Assessed by Diastolic Wall Strain Predicts Infrequent and Asymptomatic Atrial Fibrillation
Takanao Mine, Hyogo College of Medicine, Japan
SY1-5. Catheter Ablation of Silent Paroxysmal Atrial Fibrillation with Intense Follow-Up Using an Extended External Auto-Triggered Loop Recorder
Shinsuke Miyazaki, University of Fukui, Japan
2. Impact of Beta Blockades in the Treatment of Arrhythmias: From Bench to Bedside
July 25 (Thu) 14:30-16:00 Room 1 (Main Hall, 1F, Conference Center)
Chairs Katsushige Ono, Department of Pathophysiology, Oita University School of Medicine, Japan
Peng-Sheng Chen, Indiana University School of Medicine, USA
SY2-1-KL. The Importance of Beta 2 Blockade in Cardiac Arrhythmia Control
Peng-Sheng Chen, Indiana University School of Medicine, USA
SY2-2. Heart Rate Control Resistant Minor Allele of GJA-1 Gene Polymorphism in Patients with Persistent Atrial Fibrillation
Sho Okamura, Hiroshima University, Japan
SY2-3. Role of a Beta Blockade in the Management of Patients Undergoing Pulmonary Vein Isolation of Paroxysmal Atrial Fibrillation
Shinsuke Miyazaki, University of Fukui, Japan
SY2-4. Comparison between Bisoprolol Transdermal Patch and Bisoprolol Fumarate Oral Formulation in Rate Control Therapy of Circadian Variation in Patients with Permanent Atrial Fibrillation
Yohei Sawa, Division of Cardiology, Department of Internal Medicine, Iwate Medical University, Japan
3. Current Status and Future Perspective of AI-based Diagnosis of Arrhythmias
July 25 (Thu) 17:00-18:30 Room 1 (Main Hall, 1F, Conference Center)
Chairs Tetsuo Sasano, Department of Cardiovascular Physiology, Tokyo Medical and Dental University, Japan
Prashanthan Sanders, University of Adelaide, Australia
SY3-1-KL. Current Status and Perspective of the Application of Artificial Intelligence in the Diagnosis of Arrhythmia
Prashanthan Sanders, University of Adelaide, Australia
SY3-2. Deep Neural Network for Estimation of Membrane Potential Distribution from Multiple Electrode Measurement Signals—A Simulation Study
Naoki Tomii, The University of Tokyo, Japan
SY3-3. Deep Convolutional Neural Networks for the Discrimination of Patients with Paroxysmal Atrial Fibrillation on ECG at Sinus Rhythm
Ryouta Mieda, Tokyo Medical and Dental University Department of Cardiovascular Surgery, Japan
SY3-4. What Can Advances in AI Give for AF Detected by Wearables?
Keitaro Senoo, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Department of Cardiac Arrhythmia Research and Innovation, Japan
SY3-5. Future Perspective of Online Real-Time Atrial Fibrillation Visualization System Aided by Artificial Intelligence and In Silico Analysis System
Takashi Ashihara, Department of Cardiovascular Medicine, Shiga University of Medical Science, Japan
4. Automaticity of the Heart: New Insight
July 25 (Thu) 17:00-18:30 Room 2 (501+502, 5F, Conference Center)
Chairs Haruo Honjo, Research Institute of Enviromental Medicine, Nagoya University, Japan
Yael Yaniv, Biomedical Engineering,Technion – Israel Institute of Technology, Israel
SY4-1. Brain and Pacemaker Signatures in the ECG
Yael Yaniv, Biomedical Engineering,Technion–Israel Institute of Technology, Israel
SY4-2. Learn from Failure: Clock Coupling Rescues Sinoatrial Nodal Cells’ Action Potential Failure
Kenta Tsutsui, Department of Cardiovascular Medicine, Saitama International Medical Center, Faculty of Medicine, Saitama Medical University, Japan
SY4-3. Automaticity in Cardiomyocytes Derived from iPS Cells
Jong-Kook Lee, Department of Advanced Cardiovascular Regenerative Medicine Osaka University Graduate School of Medicine, Japan
SY4-4. The Reentry Circuit of Sinoatrial Reentrant Tachycardia Involves the Sinoatrial Conduction Pathways in Humans: Observation by Noncontact Mapping System
Motoki Hara, Higashihiroshima Medical Center, Japan
5. Latest Technology for Scar-related Reentrant VTs—Searching for the Optimal Endpoint
July 25 (Thu) 08:30-10:00 Room 5 (302, 3F, Conference Center)
Chairs Akihiko Nogami, Department of Cardiology, Faculty of Medicine, University of Tsukuba, Japan
Saurabh Kumar, Ventricular Arrhythmias and Sudden Cardiac Death at Westmead Hospital, Australia
SY5-1-KL.
Saurabh Kumar, Ventricular Arrhythmias and Sudden Cardiac Death at Westmead Hospital, Australia
SY5-2. Long-Term Outcome of Ventricular Tachycardia Ablation in Patients Who Did Not Undergo Ventricular Tachycardia Induction after Ablation
Takeshi Kitamura, Department of Cardiology, Tokyo Metropolitan Hiroo Hospital, Japan
SY5-3. Late Potential Abolition Strategy for VT in Patients with Non-Ischemic Cardiomyopathy
Kenji Okubo, Yokosuka Kyosai Hospital, Japan
SY5-4. Targeting the Evoked Delayed Potential Reduces VT Recurrence after Catheter Ablation in Patients with Subendocardial Myocardial Infarction
Yoshihisa Naruse, Hamamatsu University School of Medicine, Japan
SY5-5. Feasibility of Real-Time Magnetic Resonance Imaging-Guided Radiofrequency Catheter Ablation of Ventricular Tachycardia
Susumu Tao, Department of cardiovascular medicine / Heart rhythm center, Tokyo Medical and Dental University, Japan
SY5-6. Ablation of CT-Derived Wall Thickness Channels in Post-Infarction Ventricular Tachycardia: Comparison to Conventional LAVA Elimination Strategy
Masateru Takigawa, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France
6. Current Topics of Inherited Arrhythmias
July 26 (Fri) 08:30-10:00 Room 1 (Main Hall, 1F, Conference Center)
Chairs Wataru Shimizu, Department of Cardiovascular Medicine, Nippon Medical School, Japan
Naomasa Makita, National Cerebral and Cardiovascular Center Research Institute, Japan
SY6-1. A Novel Mechanism of Sinus Node Dysfunction: Intergenic Deletion between PITX2 and ANK2 Disrupts Chromatin Structure in Pacemaker Cell Differentiation
Hiroshige Murata, Nippon Medical School, Japan
SY6-2. Functional Reappraisal of SCN5A Mutations Reemphasize Their Predictive Value for Lethal Cardiac Events in Brugada Syndrome
Taisuke Ishikawa, Omics Research Center, National Cerebral and Cardiovascular Center, Japan
SY6-3. MicroRNAs and Brugada Syndrome
Yukiko Nakano, Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan
SY6-4. Significance of Exercise-Induced Ventricular Arrhythmias in patients with Brugada Syndrome
Hiroshi Morita, Cardiovascular Therapeutics, Okayama University Graduate School of Medicine, Japan
SY6-5. Quantitative Microvolt T-Wave Alternans Monitoring for Risk Assessment and Guiding Therapy in Patients with Long QT Syndrome
Nobuhiro Takasugi, Division of Cardiovascular Medicine, Gifu University Hospital, Japan
7. How to Ablate Idiopathic Ventricular Arrhythmias Difficult to Map and Access the Origins of Arrhythmias
July 26 (Fri) 10:00-11:30 Room 1 (Main Hall, 1F, Conference Center)
Chairs Hiroshi Tada, Department of Cardiovascular Medicine, Faculty of Medical Sciences,University of Fukui, Japan
Takumi Yamada, Division of Cardiovascular Disease, University of Alabama at Birmingham, USA
SY7-1-KL. Why Does Catheter Ablation Remain Challenging in Some Idiopathic Ventricular Arrhythmias?
Takumi Yamada, Division of Cardiovascular Disease, University of Alabama at Birmingham, USA
SY7-2. Outcome of Combined Radiofrequency- and Cryo-ablation in Patients with Ventricular Arrhythmias Originating from the Papillary Muscles/Moderator Band
Koji Miyamoto, Mayo Clinic, USA/ Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan
SY7-3. Challenging Radiofrequency Catheter Ablation of Idiopathic Ventricular Arrhythmias from Distal of Great Cardiac Vein or their Branches
Yasuaki Tanaka, Yokosuka Kyosai Hospital, Japan
SY7-4. Catheter Ablation of Left Ventricular Arrhythmias Using the Real-Time Three-Dimensional Anatomic Geometry from Ultrasound
Atsuyuki Watanabe, Cardiovascular of medicine,Okayama University, Japan
SY7-5. Long Duration Ablation on Left Ventricular Endocardium using Remote Magnetic Navigation System for Premature Ventricular Contraction from the Summit of Left Ventricle
Soichiro Yamashita, Heart Rhythm Center, Aijinkai Takatsuki Hospital, Osaka, Japan
SY7-6. Intramural Infusion Needle Ablation for Intractable Premature Ventricular Contractions Associated with Ventricular Dysfunction
Tomofumi Nakamura, Vanderbilt University Medical Center, USA
8. An Alarming Growth of AF Population-How to Use Oral Anticoagulants Safely
July 26 (Fri) 14:00-15:30 Room 1 (Main Hall, 1F, Conference Center)
Chairs Takeshi Yamashita, The Cardiovascular Institute, Japan
Yukihiro Koretsune, National Hospital Organization Osaka National Hospital, Japan
SY8-1-KL. State-of-the-Art
Takeshi Yamashita, The Cardiovascular Institute, Japan
SY8-2. Importance of Stroke Prevention by Appropriate Oral Anticoagulant Use in Elderly Japanese Patients—Findings from the SAKURA AF Registry
Yasuo Okumura, Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Japan
SY8-3. Clinical Characteristics and Outcomes in Elderly Japanese Patients with Nonvalvular Atrial Fibrillation: The Hokuriku-Plus AF Registry
Toyonobu Tsuda, Kanazawa University Hospital
SY8-4. Risk of Triple Antiplatelet Therapy in Atrial Fibrillation Patients Undergoing Coronary Stenting
Yukio Sekiguchi, Department of Cardiology, University of Tsukuba, Japan
SY8-5. Strategies for Ischemic and Hemorrhagic Strokes during Anticoagulation Treatments in the Era of Specific Reversal Agents
Shigeru Nogawa, Department of Neurology, Tokai University Hachioji Hospital, Japan
9. Recent Advantages in Balloon-based Atrial Fibrillation Ablation
July 26 (Fri) 16:30-18:00 Room 1 (Main Hall, 1F, Conference Center)
Chairs Kazuhiro Satomi, Heart Rhythm Center, Tokyo Medical University Hospital
Carlo De Asmundis, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Belgium
SY9-1-KL.
Carlo De Asmundis, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Belgium
SY9-2. Comparison of Acute Effect and Clinical Outcome among Various Balloon Systems in Paroxysmal Atrial Fibrillation Patients
Seigo Yamashita, The Jikei University School of Medicine, Japan
SY9-3. The Impact of Additional Freeze Cycles on Ablation Lesions and Gaps for Cryoballoon Ablation of Paroxysmal Atrial Fibrillation in the AD-Balloon Study
Koji Miyamoto, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan/Mayo Clinic, USA
SY9-4. Time to Isolation Guided Hot Balloon Ablation for Pulmonary Vein Isolation
Akio Chikata, Division of Cardiology, Department of Internal Medicine, Toyama Prefectural Central Hospital, Japan
SY9-5. Procedural Outcomes of Pulmonary Vein Isolation Using Visually Guided Laser Balloon in Japanese Patients: A Multicenter Study
Yoshihide Takahashi, Advanced Arrhythmia Research, Tokyo Medical and Dental University, Japan
SY9-6. Influence of Various Energy Settings and Overlap Ratios on Size and Continuity of Lesions in Laser Balloon Ablation in Ex Vivo Mode
Takahiko Nagase, Saitama Medical University International Medical Center, Japan
SY9-7. The Incidence of Esophageal Thermal Lesions and Gastroparesis after Luminal Esophageal Temperature-Guided Pulmonary Vein Isolation Using Radiofrequency and Cryoballoon Catheter
Yasuhiro Yoshiga, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Japan
10. Novel Strategy of Catheter Ablation for Persistent Atrial FibrillationーHow to Optimize Extra-PV Substrate Modification
July 26 (Fri) 10:00-11:30 Room 4 (301, 3F, Conference Center)
Chairs Kaoru Okishige, Yokohama City Minato Red Cross Hospital, Japan
Young-Hoon Kim, Korea University Medical College, Anam Hospital, Korea
SY10-1-KL.
Young-Hoon Kim, Korea University Medical College, Anam Hospital, Korea
SY10-2. Combined Real-Time Dominant Frequency and Phase Mapping (ExTRa Mapping) May Contribute to Identifying Important Arrhythmogenic Atrial Regions in Persistent AF
Koji Kumagai, Department of Cardiovascular Medicine, Tohoku Medical and Pharmaceutical University, Japan/Mayo Clinic, USA
SY10-3. Two-Year Follow-Up of a New Tailored Approach for Persistent Atrial Fibrillation: Early Area Defragmentation (EADF)
Masatsugu Ohe, Kurume university, Japan
SY10-4. The Effects of the Catheter Maze Procedure, "Box-Isolation+Three Mitral-Lines," on Persistent Atrial Fibrillation
Motoki Hara, Higashihiroshima Medical Center, Japan
SY10-5. Does Epicardial Marshall Vein Alcoholization Add Benefit on Conventional Endocardial RF Ablation in Perimitral Flutter?
Masateru Takigawa, CHU Bordeaux, IHU Lyric, Université de Bordeaux, France
SY10-6. Safety and Feasibility of Novel Extensive Ablation Strategy Inducing Cryoballoon Ablation for Non-Paroxysmal Atrial Fibrillation in High-Risk Patients
Takeshi Sasaki, National Disaster Medical Center, Japan
SY10-7. Impact of Posterior Wall Isolation in Conjunction with Pulmonary Vein Isolation Using Cryoballoon Ablation in Patients with Persistent Atrial Fibrillation: A Single Center Experience
Masahiro Esato, Department of arrhythmia, Ijinkai Takeda General Hospital, Japan
11. HFpEF-related Atrial Fibrillation: From Mechanism to Clinical Implication of AF and Diastolic Dysfunction
July 26 (Fri) 10:00-11:30 Room 5 (302, 3F, Conference Center)
Chairs Stanley Nattel, University of Montreal, Canada
Eiichi Watanabe, Fujita Health University School of Medicine, Japan
SY11-1-KL. Effects of Diastolic Dysfunction on the Atria and Links to Arrythmia Mechanisms
Stanley Nattel, University of Montreal, Canada
SY11-2. The Behavior of Atrial Fibrillation in Patients with Heart Failure Hospitalization—Insight from Kokura Congestive Heart Failure Registry
Masato Fukunaga, Kokura Memorial Hospital, Kitakyushu, Japan
SY11-3. Sympathetic Tone and Atrial Fibrillation in Patients with HFpEF
Peng-Sheng Chen, Indiana University School of Medicine, USA
SY11-4. The Relationship between Outcome Undergoing Pulmonary Vein Isolation and Influence of Diastolic Function in Paroxysmal Atrial Fibrillation Patients with Preserved Ejection Fraction
Takashi Komatsu, Iwate Medical University, Japan
SY11-5. Clinical Benefit of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction
Keiji Inoue, Kyoto Second Red Cross Hospital, Japan
12. S-ICD: What’s New?
July 26 (Fri) 16:30-18:00 Room 6 (303, 3F, Conference Center)
Chairs Yuji Nakazato, Department of Cardiology, Juntendo University Urayasu Hospital, Japan
Antonio Raviele, ALFA-Alliance to Fight Atrial Fibrillation, Italy
SY12-1-KL. Combined Use of S-ICD and Pacemakers: Feasibilityand Results
Antonio Raviele, ALFA-Alliance to Fight Atrial Fibrillation, Italy
SY12-2. Indication
Masahiko Takagi, Division of Cardiac Arrhythmia, Kansai Medical University Medical Center, Japan
SY12-3. Clinical Results
Chu-Pak Lau, Queen Mary Hospital, The University of Hong Kong, Hong Kong
SY12-4. Implantation-Related Complications of the Subcutaneous Implantable Cardioverter-Defibrillator: A surgical management
Katsuhiko Imai, Department of Cardiovascular Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Japan
13. Long Term Efficacy and Safety in His-bundle Pacing
July 27 (Sat) 09:00-10:30 Room 1 (Main Hall, 1F, Conference Center)
Chairs Kyoko Soejima, Kyorin University School of Medicine, Japan
Pugazhendhi Vijayaraman, Geisinger Wyoming Valley Medical Center, USA
SY13-1-KL.
Pugazhendhi Vijayaraman, Geisinger Wyoming Valley Medical Center, USA
SY13-2. Implantation Technique and ECG Characteristic of Left Bundle Branch Pacing
Weijian Huang, Department of Cardiology, the First affiliated Hospital of Wenzhou Medical University, China
SY13-3. Characteristics of His-Bundle Electrogram at Implant Related to Pacing Threshold After Implant
Toshiaki Sato, Kyorin University, Medical School, Division of Advanced Arrhythmia Management, Japan
SY13-4. Predictors of Adequate Placement of His-Bundle Pacing Lead
Shinji Mito, Tsuchiya General Hospital, Japan
SY13-5. Efficacy and Safety of Monthly Remote Monitoring in His-Bundle Pacing Patients
Daisuke Yoshimoto, Toyohashi Heart Center, Toyohashi, Japan
SY13-6. A Comparison of Hemodynamic Parameters between His Bundle Pacing and Biventricular Pacing in CRT-indicated Patients with Left Bundle Branch Block
Hiroyuki Kato, Division of Cardiology, JCHO Chukyo Hospital, Japan
14. Unresolved Issues of Cardiac Device and Lead Extraction
July 27 (Sat) 10:30-12:00 Room 1 (Main Hall, 1F, Conference Center)
Chairs Morio Shoda, Department of Cardiology, Tokyo Women's Medical University, Japan
Bruce L. Wilkoff, Cleveland Clinic Lerner College of Medicine of CWRU, USA
SY14-1-KL.
Bruce L. Wilkoff, Cleveland Clinic Lerner College of Medicine of CWRU, USA
SY14-2. Various Methods of Lead Extraction in Patients with Large Vegetation
Nobuhiro Nishii, Department of Cardiovascular Therapeutics, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan
SY14-3. Clinical and Procedural Features of Left Ventricular Lead Extraction in Patients with Cardiac Resynchronization Therapy
Daigo Yagishita, Department of Cardiology, Tokyo Women's Medical University, Japan
SY14-4. Predictors of Bailout Femoral Approach in Transvenous Lead Extraction: A Propensity-Matched Analysis
Tsuyoshi Isawa, Sendai Kousei Hospital, Japan
15. Clinical Impact and Indication of Novel Devices and Surgical Procedures for Left Atrial Appendage Closure
July 27 (Sat) 13:50-15:20 Room 1 (Main Hall, 1F, Conference Center)
Chairs Takashi Nitta, Cardiovascular Surgery, Nippon Medical School, Japan
Haruhiko Abe, Department of Heart Rhythm Management, University of Occupational & Enviromental Health, Japan
SY15-1. Predictors of Incomplete Occlusion of the Left Atrial Appendage in Patients with a WATCHMAN Device Implantation
Koji Miyamoto, Division of Cardiovascular Diseases, Mayo Clinic, USA/ Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Japan
SY15-2. The Effect of Percutaneous Left Atrial Appendage Suture Ligation on Left Atrial Physiology
Hiroyuki Ito, Division of Cardiology, Department of Medicine, Showa University, Japan
SY15-3. Efficacy and Safety of Thoracoscopic Left Atrial Appendectomy in Patients with persistent Atrial Fibrillation
Yoko Ito, Tsukuba Memorial Hospital, Japan
SY15-4. Thoracoscopic Stand-Alone Left Atrial Appendage Closure with Stapler-And-Loop Technique in Non-Valvular Atrial Fibrillation: Mid-Term Results of 201 Cases
Toshiya Ohtsuka, Tokyo Metropolitan Tama Medical Center, Japan
SY15-5. 12-Months Outcome After Left Atrial Appendage Closure in Japanese Patients: Lesson from the SALUTE Trial
Hiro Yamasaki, University of Tsukuba, Japan
16. Emerging 3-D Mapping Systems for Diagnosis and Management of Arrhythmias
July 27 (Sat) 09:00-10:30 Room 5 (302, 3F, Conference Center)
Chairs Ichiro Sakuma, School of Engineering, The University of Tokyo, Japan
Hiroshi Nakagawa, Heart Rhythm Institute, University of Oklahoma Health Sciences Center, USA
SY16-1-KL.
Hiroshi Nakagawa, Heart Rhythm Institute, University of Oklahoma Health Sciences Center, USA
SY16-2. Comparison of Technological Features of High-density Mapping Systems
Yasuaki Tanaka, Yokosuka Kyosai Hospital, Japan
SY16-3. Mapping of Atrial Fibrillation Using a Novel Mapping Module: CARTOFINDER
Yoshihide Takahashi, Advanced Arrhythmia Research, Tokyo Medical and Dental University, Japan
SY16-4. Fluoro-Reduction Strategy with ACL and 3D Image-Integration
Satoru Sakagami, National Hospital Organization Kanazawa Medical Center, Japan
SY16-5. Catheter Ablation Performed in the Early Post-Operative Period after Congenital Heart Surgery
Jun Yoshimoto, Department of Cardiology, Shizuoka Children's Hospital, Shizuoka Japan
Meet the Asian Leaders
History, Scientific Contribution and Future Perspective of APHRS and the Expected Role of JHRS
July 25 (Thu) 11:15-12:30 Room 4 (301, 3F, Conference Center)
Chairs Wataru Shimizu, Department of Cardiovascular Medicine, Nippon Medical School, Japan
Tachapong Ngarmukos, Ramathibodi Hospital, Mahidol University, Thailand
Angelo Auricchio, Cardiocentro Ticino, Switzerland
Thomas F. Deering, Piedmont Hospital, USA
MAL-1. History of APHRS
Shih-Ann Chen, Taipei Veterans General Hospital, Taiwan
MAL-2. Scientific Contributions of APHRS
Young-Hoon Kim, Korea University Medical College, Anam Hospital, Korea
MAL-3. Intercontinental Relationship of APHRS with HRS and EHRA
Jonathan M. Kalman, Department of Medicine, University of Melbourne, Australia/Heart Rhythm Services, Royal Melbourne Hospital, Australia
MAL-4. Public Education Efforts and Fruitful Outcome in Asian Pacific Countries
Wee Siong Teo, National Heart Centre Singapore, Singapore
MAL-5. Future Perspective of APHRS
Chu-Pak Lau, Queen Mary Hospital, The University of Hong Kong, Hong Kong
MAL-6. The Expected Role of JHRS in APHRS
Kyoko Soejima, Kyorin University School of Medicine, Japan
MAL-7. Short Remark
Masayasu Hiraoka, Hiraoka-Clinic, Japan
Special Program
1.
Complex Fractionated Atrial Elecatrogram Guided Ablation
—Further Learning More Refined Targets in AF Ablation
July 25 (Thu) 16:00-17:00 Room 7 (304, 3F, Conference Center)
Chairs Julien Seitz,Hôpital Saint Joseph, France
Kohei Yamashiro, Heart Rhythm Center, Aijinkai Takatsuki Hospital, Japan
SP1-1. Historical Perspective of Complex Fractionated Atrial Elecatrogram Guided Ablation
Naoya Oketani, Cardiovascular Medicine, Kagoshima City Hospital, Japan
SP1-2. Spatiotemporal Electrogram Dispersion Guided Ablation: What is different from Historical CFAE Ablation?
Julien Seitz, Hôpital Saint Joseph, France
SP1-3. Background of STD Guided Ablation from Translational Research
Masatoshi Yamazaki, Medical Device Development and Regulation Research Center, The University of Tokyo, Japan
3. Current Status and Future Perspective in the Pharmacological Antiarrhythmic Therapy
July 26 (Fri) 08:30-10:00 Room 4 (301, 3F, Conference Center)
Chairs Takeshi Yamashita,The Cardiovascular Institute, Japan
Tetsushi Furukawa, Department of Bio-informational Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, Japan
SP3-1. Channel Gating Modifiers as Novel and Effective, Antiarrhythmic Drug Therapy
Hraryer S. Karagueuzian, David Geffen School of Medicine at UCLA, USA
SP3-2. How to Use a New Channel Drug Ivabradine
Tomomi Ide, Kyushu University Hospital, Japan
SP3-3. Arrhythmia Treatment Targeting Rysnodinereceptor
Shigeki Kobayashi, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine, Japan
SP3-4. How Can We Use Existing Antiarrhthmicssafely
Takashi Komatsu, Division of Cardiology, Department of Internal Medicine, Iwate Medical University, Japan
4. Message from US Specialists in the Management of CIED Infection
July 26 (Fri) 11:30-12:30 Room 7 (304, 3F, Conference Center)
Chairs & Speakers Charles J. Love, Johns Hopkins School of Medicine, USA
Bruce L. Wilkoff, Cardiac Pacing & Tachyarrhythmia Devices, Department of Cardiovascular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, USA
HRS-JHRS Joint Symposium (HRS-JHRS)
Tough Cases! (Ablation and Devices)
July 27 (Sat) 10:30-12:00 Room 4 (301, 3F, Conference Center)
Chairs Akihiko Nogami, Department of Cardiology, Faculty of Medicine, University of Tsukuba, Japan
Thomas F. Deering, Piedmont Hospital, USA
HRS-JHRS-1-KL. Talk International Relationship between HRS and JHRS
Thomas F. Deering, Piedmont Hospital, USA
HRS-JHRS-2. Touch Ablation Cases
Samuel J. Asirvatham, Mayo Clinic, USA
HRS-JHRS-3. Touch Device Cases
Pugazhendhi Vijayaraman, Geisinger Wyoming Valley Medical Center, USA
HRS-JHRS-4. Catheter Ablation of Biatrial Tachycardia: A Journey to the Final Destination
Shigeki Kusa, Cardiovascular Division, Tsuchiura Kyodo Hospital, Japan
HRS-JHRS-5. Device (JHRS)
Katsuhito Fujiu, Department of Cardiovascular Medicine, The University of Tokyo, Japan
EHRA-JHRS Joint Symposium
The Current Perspective in Ablation Therapy
July 25 (Thu) 08:30-10:00 Room 4 (301, 3F, Conference Center)
Chairs Takashi Kurita, Division of Cardiovascular Center, Kindai University, Japan
Angelo Auricchio, Cardiocentro Ticino, Switzerland
EHRA-JHRS-1. LAA as Substrate of AF
Seiichiro Matsuo, Jikei University Katsushika Medical Center, Japan
EHRA-JHRS-2. Qdot -Novel RF Energy Delivery-
Josef Kautzner, Institute for Clinical Experimental Medicne (IKEM), Czech Republic
EHRA-JHRS-3. Hybrid Thoracoscopic Epicardial Ablation in Patients with Brugada Syndrome
Carlo De Asmundis, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Belgium
EHRA-JHRS-4. MRI as a Modality for Evaluating Pre-Ablation Structural Remodeling of Left Atrium-From Past to Future Perspective
Koji Higuchi, Hiratsuka Kyosai Hospital, Japan
APHRS-JHRS Joint Symposium
Malignant Ventricular Arrhythmias－Current Topics of Mapping and Catheter Ablation－
July 25 (Thu) 10:00-11:15 Room 4 (301, 3F, Conference Center)
Chairs Kyoko Soejima, Kyorin University School of Medicine, Japan
Jonathan M. Kalman, Department of Medicine, University of Melbourne, Australia/Heart Rhythm Services, Royal Melbourne Hospital, Australia
1. Catheter Ablation of Lamin Cardiomyopathy, LV Non Compaction, Hypertrophic Cardiomyopathy and Other Unusual Substrates
Saurabh Kumar, Westmead Hospital, Australia
2. Thermal Effect on the Development of Malignant Ventricular Arrhythmias in Brugada Syndrome
Fa-Po Chung, Taipei Veterans General Hospital, Taiwan
3. Epicardial VT in Non-Ischemic Cardiomyopathy: Unsolved Difficulty
Yukio Sekiguchi, Depatment of Cardiology, Faculty of Medicine, University of Tsukuba, Japan
4. Substrates and Trigger Ablation of Patients with Long QT Syndrome
Yoga Yuniadi, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, and National Cardiovascular Center Harapan Kita, Indonesia